NBSE Chart
See on advanced chart >
About
NeuBase Therapeutics, Inc. is a Delaware corporation that was organized on August 4, 2009. The company is a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines. Their modular peptide-nucleic acid antisense oligo...
Read More
- HighlightA pre-clinical stage biopharmaceutical company that developing therapies for rare genetic diseases and cancers caused by mutant genes
- ExchangeNASDAQ
- Listing Date06/13/2013
- Established Date08/04/2009
- Full-time Employees37
- Address350 Technology Drive Pittsburgh PA 15219
- Tel1-412-7633350
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry